Nancy Miller-Rich

Insider Reports History

Location
New York, NY
Signature
/s/ Scott Bizily as Attorney-in-Fact for Nancy Miller-Rich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Miller-Rich:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aldeyra Therapeutics, Inc. Director Common Stock 922 $9,340 $10.13 12 Apr 2023 Direct
4D Molecular Therapeutics, Inc. Director Stock Option (Right to Buy) 22,500 17 Jun 2025 Direct
Aldeyra Therapeutics, Inc. Director Stock Option (Right to Buy) 2,413 10 Jun 2025 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 08 Nov 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 08 Nov 2023 Direct
Kadmon Holdings, Inc. Director Stock Option (right to buy) 0 $5.54 09 Nov 2021 Direct

Insider Reports Filed by Nancy Miller-Rich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FDMT 4D Molecular Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:04
ALDX Aldeyra Therapeutics, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 16:30
ALDX Aldeyra Therapeutics, Inc. 04 Jun 2024 2 $0 4 Director 06 Jun 2024, 16:12
FDMT 4D Molecular Therapeutics, Inc. 21 May 2024 1 $0 4 Director 23 May 2024, 19:12
/report/000110465923117105-miller-rich-nancy-2023-11-08 INTERCEPT PHARMACEUTICALS, INC. 08 Nov 2023 8 -$577,885 4 Director 13 Nov 2023, 14:44
ALDX Aldeyra Therapeutics, Inc. 30 Jun 2023 2 $0 4 Director 05 Jul 2023, 17:42
/report/000110465923064840-miller-rich-nancy-2023-05-24 INTERCEPT PHARMACEUTICALS, INC. 24 May 2023 2 $0 4 Director 25 May 2023, 20:38
FDMT 4D Molecular Therapeutics, Inc. 23 May 2023 1 $0 4 Director 25 May 2023, 19:37
ALDX Aldeyra Therapeutics, Inc. 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 17:07
/report/000110465922065906-miller-rich-nancy-2022-05-25 INTERCEPT PHARMACEUTICALS, INC. 25 May 2022 2 $0 4 Director 27 May 2022, 16:17
FDMT 4D Molecular Therapeutics, Inc. 23 May 2022 1 $0 4 Director 25 May 2022, 19:02
/report/000110465921136405-miller-rich-nancy-2021-11-09 Kadmon Holdings, Inc. 09 Nov 2021 2 -$767,912 4 Director 09 Nov 2021, 16:38
ALDX Aldeyra Therapeutics, Inc. 08 Jun 2021 2 $0 4 Director 10 Jun 2021, 17:46
/report/000110465921075220-miller-rich-nancy-2021-05-27 INTERCEPT PHARMACEUTICALS, INC. 27 May 2021 2 $0 4 Director 01 Jun 2021, 19:02
FDMT 4D Molecular Therapeutics Inc. 17 May 2021 1 $0 4 Director 19 May 2021, 20:32
/report/000159396821001314-miller-rich-nancy-2021-05-12 Kadmon Holdings, Inc. 12 May 2021 1 $0 4 Director 13 May 2021, 16:16
ALDX Aldeyra Therapeutics, Inc. 03 May 2021 2 +$10,447 4 Director 21 Oct 2024, 20:22